alpha-aminopyridine has been researched along with Carotid Stenosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bot, I; Bot, M; de Vries, H; Foks, AC; Ijzerman, AP; Korporaal, SJ; Kuiper, J; Ter Borg, MN; van Berkel, TJ; van Santbrink, PJ; van Veldhoven, J | 1 |
1 other study(ies) available for alpha-aminopyridine and Carotid Stenosis
Article | Year |
---|---|
Adenosine A₂B receptor agonism inhibits neointimal lesion development after arterial injury in apolipoprotein E-deficient mice.
Topics: Adenosine A2 Receptor Agonists; Aminopyridines; Animals; Apolipoproteins E; Cardiovascular Agents; Carotid Artery Injuries; Carotid Artery, Common; Carotid Stenosis; Cell Adhesion; Cell Proliferation; CHO Cells; Collagen; Cricetinae; Cricetulus; Dietary Fats; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; HEK293 Cells; Humans; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Neutrophil Activation; Neutrophils; Platelet Activation; Receptor, Adenosine A2B; Time Factors; Transfection | 2012 |